Examiner: HOPKINS, SAMANTHA LAKE

Tech Center 1600 • Art Units: 1641 1674 1692

This examiner grants 55% of resolved cases

Performance Statistics

55.3%

Allow Rate

-4.7% vs TC avg

Total Applications

+63.4%

Interview Lift

1409

Avg Prosecution Days

Based on 47 resolved cases, 2023–2026

1.5%

§101 Eligibility

15.9%

§102 Novelty

25.2%

§103 Obviousness

34.8%

§112 Clarity

App #	Title	Status	Assignee
18260125	ANTI-N3pGlu AMYLOID BETA ANTIBODIES AND USES THEREOF	Non-Final OA	Eli Lilly and Company
17244864	METHODS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION	Final Rejection	Regeneron Pharmaceuticals, Inc.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.